Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.

about

Durability, safety, and efficacy of rilpivirine in clinical practice: results from the SCOLTA Project.

Item

http://www.wikidata.org/entity/Q54942910

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Durability, safety, and effica ...... sults from the SCOLTA Project.

@en

Durability, safety, and effica ...... sults from the SCOLTA Project.

@nl

type

Item

label

Durability, safety, and effica ...... sults from the SCOLTA Project.

@en

Durability, safety, and effica ...... sults from the SCOLTA Project.

@nl

prefLabel

Durability, safety, and effica ...... sults from the SCOLTA Project.

@en

Durability, safety, and effica ...... sults from the SCOLTA Project.

@nl

P1476

Durability, safety, and effica ...... esults from the SCOLTA Project

@en

P2093

Barbara Menzaghi

http://www.w3.org/2001/XMLSchema#string

Benedetto Maurizio Celesia

http://www.w3.org/2001/XMLSchema#string

C.I.S.A.I. Study Group, Italy

http://www.w3.org/2001/XMLSchema#string

Canio Martinelli

http://www.w3.org/2001/XMLSchema#string

Chiara Dentone

http://www.w3.org/2001/XMLSchema#string

Francesca Vichi

http://www.w3.org/2001/XMLSchema#string

Giancarlo Orofino

http://www.w3.org/2001/XMLSchema#string

Giordano Madeddu

http://www.w3.org/2001/XMLSchema#string

Giovanni Penco

http://www.w3.org/2001/XMLSchema#string

Giustino Parruti

http://www.w3.org/2001/XMLSchema#string

P2860

Simplification to co-formulated rilpivirine/emtricitabine/tenofovir in virologically suppressed patients: Data from a multicenter cohort.

Efficacy and safety in clinical practice of a rilpivirine, tenofovir and emtricitabine single-tablet regimen in virologically suppressed HIV-positive patients on stable antiretroviral therapy.

Rilpivirine inhibits drug transporters ABCB1, SLC22A1, and SLC22A2 in vitro

Rilpivirine versus efavirenz with emtricitabine/tenofovir disoproxil fumarate in treatment-naïve HIV-1-infected patients with HIV-1 RNA ≤100,000 copies/mL: week 96 pooled ECHO/THRIVE subanalysis

Cobicistat : a new opportunity in the treatment of HIV disease?

The problem of renal function monitoring in patients treated with the novel antiretroviral drugs.

Summary estimates of cholesterol used to predict coronary heart disease.

Muscle symptoms and creatine phosphokinase elevations in patients receiving raltegravir in clinical practice: Results from the SCOLTA project long-term surveillance.

Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants.

Week 48 results from a randomized clinical trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate vs. efavirenz/emtricitabine/tenofovir disoproxil fumarate in treatment-naive HIV-1-infected adults.

P304

615-623

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IDR.S152090

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Elena Ricci

Antonio Di Biagio

Giuseppe Vittorio Luigi De Socio

P577

2018-04-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29731650

http://www.w3.org/2001/XMLSchema#string

P932

5927182

http://www.w3.org/2001/XMLSchema#string